Teladoc Health, Inc. — Form 10-Q
Filed October 29, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Adam C. Vandervoort, Chief Legal Officer and Secretary, resigned effective November 1, 2026, treated as termination for Good Reason under his severance agreement. He receives 12 months base salary continuation, 12 months COBRA premium support, immediate vesting of equity scheduled to vest within 12 months, and one year unpaid advisory services with NYC office access (max 20% time commitment). He executed broad release of all claims including ADEA, with 7-day revocation right.
Why this rating
CLO departure is routine executive transition. Severance obligations (base + COBRA + equity acceleration) are material to individual but unknown in aggregate dollar size relative to $1.5B market cap. No business disruption stated. Standard separation governance.
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.